We are live on ! Find out more
LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

46 hedge funds and large institutions have $27.9M invested in Lumos Pharma, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 9 increasing their positions, 19 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less capital invested

Capital invested by funds: $30.5M → $27.9M (-$2.6M)

28% less funds holding

Funds holding: 64 → 46 (-18)

53% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 19

55% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 29

72% less call options, than puts

Call options by funds: $467K | Put options by funds: $1.67M

Holders
46
Holders Change
-18
Holders Change %
-28.13%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
9
Reduced
19
Closed
29
Calls
$467K
Puts
$1.67M
Net Calls
-$1.2M
Net Calls Change
-$365K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$13.1M
2
NMC
NEA Management Company
Maryland
+$7.36M
3
Blackstone Inc
Blackstone Inc
New York
+$6.54M
4
JG
Jefferies Group
New York
+$1.49M
5
LPC
Lion Point Capital
New York
+$854K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.3M
2
Two Sigma Investments
Two Sigma Investments
New York
-$849K
3
QI
QS Investors
New York
-$270K
4
Invesco
Invesco
Georgia
-$265K
5
RCM
Requisite Capital Management
Texas
-$253K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$11K +$9.41K +673 +112%
TRCT
27
Tower Research Capital (TRC)
New York
$9K +$13.5K +969 +1,309%
Morgan Stanley
28
Morgan Stanley
New York
$6K -$71.3K -5,104 -89%
IA
29
IFP Advisors
Florida
$4K -$60.3K -4,314 -92%
US Bancorp
30
US Bancorp
Minnesota
$3K – – –
PAM
31
Panagora Asset Management
Massachusetts
$2K -$89K -6,369 -97%
MAM
32
Meeder Asset Management
Ohio
$2K -$2.5K -179 -43%
BWM
33
BerganKDV Wealth Management
Minnesota
$2K -$14 -1 -0.5%
MA
34
MCF Advisors
Kentucky
$2K -$14 -1 -0.5%
SFS
35
Sowell Financial Services
Arkansas
$2K -$14 -1 -0.4%
Federated Hermes
36
Federated Hermes
Pennsylvania
$1K -$797 -57 -36%
CFGS
37
Concourse Financial Group Securities
Alabama
$1K -$14 -1 -1%
Northwestern Mutual Wealth Management
38
Northwestern Mutual Wealth Management
Wisconsin
$1K -$14 -1 -1%
Fifth Third Bancorp
39
Fifth Third Bancorp
Ohio
$1K – – –
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
$1K – – –
Fidelity Investments
41
Fidelity Investments
Massachusetts
$1K +$1.55K +111 New
CFN
42
Cordasco Financial Network
Florida
$1K +$1.69K +121 New
Acadian Asset Management
43
Acadian Asset Management
Massachusetts
– -$1.3M -57,069 Closed
Two Sigma Investments
44
Two Sigma Investments
New York
– -$849K -37,288 Closed
QI
45
QS Investors
New York
– -$270K -13,245 Closed
Invesco
46
Invesco
Georgia
– -$265K -11,638 Closed
RCM
47
Requisite Capital Management
Texas
– -$253K -11,111 Closed
Jacobs Levy Equity Management
48
Jacobs Levy Equity Management
New Jersey
– -$241K -10,574 Closed
OAM
49
Oxford Asset Management
United Kingdom
– -$215K -9,443 Closed
Bank of New York Mellon
50
Bank of New York Mellon
New York
– -$181K -7,949 Closed
1
2
3

LUMO Hedge Fund Activity: Q1 2020 in Review

46 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q1 2020, worth a combined $27.9M — down 8.5% from $30.5M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of LUMO and 13 opened new positions — a net loss of 16 holders — while 19 trimmed existing stakes and 9 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $13.1M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $1.3M sold.

  • 46 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q1 2020, down from 64 in Q4 2019.
  • Funds reported $27.9M of Lumos Pharma, Inc. Common Stock stock for Q1 2020, down 8.5% quarter-over-quarter.
  • 13 funds opened new Lumos Pharma, Inc. Common Stock positions in Q1 2020 and 29 closed out, a net change of -16 holders.
  • The largest Lumos Pharma, Inc. Common Stock buyer in Q1 2020 was Deerfield Management, an estimated $13.1M added.
  • The largest Lumos Pharma, Inc. Common Stock seller in Q1 2020 was Acadian Asset Management, an estimated $1.3M sold.

Based on aggregated 13F filings for Q1 2020.